List of Tables
Table 1. Global Safety Lancets for Diabetes Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Safety Lancets for Diabetes Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Safety Lancets for Diabetes Market Competitive Situation by Manufacturers in 2024
Table 4. Global Safety Lancets for Diabetes Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Safety Lancets for Diabetes Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Safety Lancets for Diabetes Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Safety Lancets for Diabetes Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Safety Lancets for Diabetes Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Safety Lancets for Diabetes, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Safety Lancets for Diabetes, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Safety Lancets for Diabetes, Product Type & Application
Table 12. Global Key Manufacturers of Safety Lancets for Diabetes, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Safety Lancets for Diabetes by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Safety Lancets for Diabetes as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Safety Lancets for Diabetes Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Safety Lancets for Diabetes Sales by Region (2020-2025) & (K Units)
Table 18. Global Safety Lancets for Diabetes Sales Market Share by Region (2020-2025)
Table 19. Global Safety Lancets for Diabetes Sales by Region (2026-2031) & (K Units)
Table 20. Global Safety Lancets for Diabetes Sales Market Share by Region (2026-2031)
Table 21. Global Safety Lancets for Diabetes Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Safety Lancets for Diabetes Revenue Market Share by Region (2020-2025)
Table 23. Global Safety Lancets for Diabetes Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Safety Lancets for Diabetes Revenue Market Share by Region (2026-2031)
Table 25. North America Safety Lancets for Diabetes Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Safety Lancets for Diabetes Sales by Country (2020-2025) & (K Units)
Table 27. North America Safety Lancets for Diabetes Sales by Country (2026-2031) & (K Units)
Table 28. North America Safety Lancets for Diabetes Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Safety Lancets for Diabetes Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Safety Lancets for Diabetes Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Safety Lancets for Diabetes Sales by Country (2020-2025) & (K Units)
Table 32. Europe Safety Lancets for Diabetes Sales by Country (2026-2031) & (K Units)
Table 33. Europe Safety Lancets for Diabetes Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Safety Lancets for Diabetes Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Safety Lancets for Diabetes Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Safety Lancets for Diabetes Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Safety Lancets for Diabetes Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Safety Lancets for Diabetes Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Safety Lancets for Diabetes Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Safety Lancets for Diabetes Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Safety Lancets for Diabetes Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Safety Lancets for Diabetes Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Safety Lancets for Diabetes Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Safety Lancets for Diabetes Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Safety Lancets for Diabetes Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Safety Lancets for Diabetes Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Safety Lancets for Diabetes Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Safety Lancets for Diabetes Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Safety Lancets for Diabetes Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Safety Lancets for Diabetes Sales (K Units) by Type (2020-2025)
Table 51. Global Safety Lancets for Diabetes Sales (K Units) by Type (2026-2031)
Table 52. Global Safety Lancets for Diabetes Sales Market Share by Type (2020-2025)
Table 53. Global Safety Lancets for Diabetes Sales Market Share by Type (2026-2031)
Table 54. Global Safety Lancets for Diabetes Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Safety Lancets for Diabetes Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Safety Lancets for Diabetes Revenue Market Share by Type (2020-2025)
Table 57. Global Safety Lancets for Diabetes Revenue Market Share by Type (2026-2031)
Table 58. Global Safety Lancets for Diabetes Price (US$/Unit) by Type (2020-2025)
Table 59. Global Safety Lancets for Diabetes Price (US$/Unit) by Type (2026-2031)
Table 60. Global Safety Lancets for Diabetes Sales (K Units) by Application (2020-2025)
Table 61. Global Safety Lancets for Diabetes Sales (K Units) by Application (2026-2031)
Table 62. Global Safety Lancets for Diabetes Sales Market Share by Application (2020-2025)
Table 63. Global Safety Lancets for Diabetes Sales Market Share by Application (2026-2031)
Table 64. Global Safety Lancets for Diabetes Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Safety Lancets for Diabetes Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Safety Lancets for Diabetes Revenue Market Share by Application (2020-2025)
Table 67. Global Safety Lancets for Diabetes Revenue Market Share by Application (2026-2031)
Table 68. Global Safety Lancets for Diabetes Price (US$/Unit) by Application (2020-2025)
Table 69. Global Safety Lancets for Diabetes Price (US$/Unit) by Application (2026-2031)
Table 70. Roche Company Information
Table 71. Roche Description and Business Overview
Table 72. Roche Safety Lancets for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Roche Safety Lancets for Diabetes Product
Table 74. Roche Recent Developments/Updates
Table 75. BD Company Information
Table 76. BD Description and Business Overview
Table 77. BD Safety Lancets for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. BD Safety Lancets for Diabetes Product
Table 79. BD Recent Developments/Updates
Table 80. Ascensia Company Information
Table 81. Ascensia Description and Business Overview
Table 82. Ascensia Safety Lancets for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Ascensia Safety Lancets for Diabetes Product
Table 84. Ascensia Recent Developments/Updates
Table 85. Lifescan Company Information
Table 86. Lifescan Description and Business Overview
Table 87. Lifescan Safety Lancets for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Lifescan Safety Lancets for Diabetes Product
Table 89. Lifescan Recent Developments/Updates
Table 90. B. Braun Company Information
Table 91. B. Braun Description and Business Overview
Table 92. B. Braun Safety Lancets for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. B. Braun Safety Lancets for Diabetes Product
Table 94. B. Braun Recent Developments/Updates
Table 95. Terumo Company Information
Table 96. Terumo Description and Business Overview
Table 97. Terumo Safety Lancets for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Terumo Safety Lancets for Diabetes Product
Table 99. Terumo Recent Developments/Updates
Table 100. Nipro Company Information
Table 101. Nipro Description and Business Overview
Table 102. Nipro Safety Lancets for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Nipro Safety Lancets for Diabetes Product
Table 104. Nipro Recent Developments/Updates
Table 105. Cardinal Health Company Information
Table 106. Cardinal Health Description and Business Overview
Table 107. Cardinal Health Safety Lancets for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Cardinal Health Safety Lancets for Diabetes Product
Table 109. Cardinal Health Recent Developments/Updates
Table 110. ARKRAY Company Information
Table 111. ARKRAY Description and Business Overview
Table 112. ARKRAY Safety Lancets for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. ARKRAY Safety Lancets for Diabetes Product
Table 114. ARKRAY Recent Developments/Updates
Table 115. ICU Medical Company Information
Table 116. ICU Medical Description and Business Overview
Table 117. ICU Medical Safety Lancets for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. ICU Medical Safety Lancets for Diabetes Product
Table 119. ICU Medical Recent Developments/Updates
Table 120. Owen Mumford Company Information
Table 121. Owen Mumford Description and Business Overview
Table 122. Owen Mumford Safety Lancets for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Owen Mumford Safety Lancets for Diabetes Product
Table 124. Owen Mumford Recent Developments/Updates
Table 125. HemoCue Company Information
Table 126. HemoCue Description and Business Overview
Table 127. HemoCue Safety Lancets for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. HemoCue Safety Lancets for Diabetes Product
Table 129. HemoCue Recent Developments/Updates
Table 130. Greiner Bio One Company Information
Table 131. Greiner Bio One Description and Business Overview
Table 132. Greiner Bio One Safety Lancets for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Greiner Bio One Safety Lancets for Diabetes Product
Table 134. Greiner Bio One Recent Developments/Updates
Table 135. HTL-STREFA Company Information
Table 136. HTL-STREFA Description and Business Overview
Table 137. HTL-STREFA Safety Lancets for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. HTL-STREFA Safety Lancets for Diabetes Product
Table 139. HTL-STREFA Recent Developments/Updates
Table 140. Sarstedt Company Information
Table 141. Sarstedt Description and Business Overview
Table 142. Sarstedt Safety Lancets for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Sarstedt Safety Lancets for Diabetes Product
Table 144. Sarstedt Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Safety Lancets for Diabetes Distributors List
Table 148. Safety Lancets for Diabetes Customers List
Table 149. Safety Lancets for Diabetes Market Trends
Table 150. Safety Lancets for Diabetes Market Drivers
Table 151. Safety Lancets for Diabetes Market Challenges
Table 152. Safety Lancets for Diabetes Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Safety Lancets for Diabetes
Figure 2. Global Safety Lancets for Diabetes Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Safety Lancets for Diabetes Market Share by Type: 2024 & 2031
Figure 4. Safety Lancets with Needle Product Picture
Figure 5. Safety Lancets with Blade Product Picture
Figure 6. Global Safety Lancets for Diabetes Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Safety Lancets for Diabetes Market Share by Application: 2024 & 2031
Figure 8. Hospital & Clinics
Figure 9. Home
Figure 10. Other
Figure 11. Global Safety Lancets for Diabetes Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Safety Lancets for Diabetes Market Size (2020-2031) & (US$ Million)
Figure 13. Global Safety Lancets for Diabetes Sales (2020-2031) & (K Units)
Figure 14. Global Safety Lancets for Diabetes Average Price (US$/Unit) & (2020-2031)
Figure 15. Safety Lancets for Diabetes Report Years Considered
Figure 16. Safety Lancets for Diabetes Sales Share by Manufacturers in 2024
Figure 17. Global Safety Lancets for Diabetes Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Safety Lancets for Diabetes Players: Market Share by Revenue in Safety Lancets for Diabetes in 2024
Figure 19. Safety Lancets for Diabetes Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Safety Lancets for Diabetes Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Safety Lancets for Diabetes Sales Market Share by Country (2020-2031)
Figure 22. North America Safety Lancets for Diabetes Revenue Market Share by Country (2020-2031)
Figure 23. United States Safety Lancets for Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Safety Lancets for Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Safety Lancets for Diabetes Sales Market Share by Country (2020-2031)
Figure 26. Europe Safety Lancets for Diabetes Revenue Market Share by Country (2020-2031)
Figure 27. Germany Safety Lancets for Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Safety Lancets for Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Safety Lancets for Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Safety Lancets for Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Safety Lancets for Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Safety Lancets for Diabetes Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Safety Lancets for Diabetes Revenue Market Share by Region (2020-2031)
Figure 34. China Safety Lancets for Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Safety Lancets for Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Safety Lancets for Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Safety Lancets for Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Safety Lancets for Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Safety Lancets for Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Safety Lancets for Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Latin America Safety Lancets for Diabetes Sales Market Share by Country (2020-2031)
Figure 42. Latin America Safety Lancets for Diabetes Revenue Market Share by Country (2020-2031)
Figure 43. Mexico Safety Lancets for Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Brazil Safety Lancets for Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Argentina Safety Lancets for Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Middle East and Africa Safety Lancets for Diabetes Sales Market Share by Country (2020-2031)
Figure 47. Middle East and Africa Safety Lancets for Diabetes Revenue Market Share by Country (2020-2031)
Figure 48. Turkey Safety Lancets for Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Safety Lancets for Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. UAE Safety Lancets for Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Global Sales Market Share of Safety Lancets for Diabetes by Type (2020-2031)
Figure 52. Global Revenue Market Share of Safety Lancets for Diabetes by Type (2020-2031)
Figure 53. Global Safety Lancets for Diabetes Price (US$/Unit) by Type (2020-2031)
Figure 54. Global Sales Market Share of Safety Lancets for Diabetes by Application (2020-2031)
Figure 55. Global Revenue Market Share of Safety Lancets for Diabetes by Application (2020-2031)
Figure 56. Global Safety Lancets for Diabetes Price (US$/Unit) by Application (2020-2031)
Figure 57. Safety Lancets for Diabetes Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
